Silverfin false false 31/10/2024 31/10/2024 01/11/2023 no description of principal activity Benjamin Thomson 26/10/2016 Bethany Thomson 26/10/2016 Jonathan Thomson 26/10/2016 Simon James Thomson 26/10/2016 10446033 2024-10-31 10446033 bus:Director1 2024-10-31 10446033 bus:Director2 2024-10-31 10446033 bus:Director3 2024-10-31 10446033 bus:Director4 2024-10-31 10446033 2023-10-31 10446033 core:CurrentFinancialInstruments 2024-10-31 10446033 core:CurrentFinancialInstruments 2023-10-31 10446033 2023-11-01 2024-10-31 10446033 bus:Micro-entities 2023-11-01 2024-10-31 10446033 bus:FilletedAccounts 2023-11-01 2024-10-31 10446033 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 10446033 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 10446033 bus:Director1 2023-11-01 2024-10-31 10446033 bus:Director2 2023-11-01 2024-10-31 10446033 bus:Director3 2023-11-01 2024-10-31 10446033 bus:Director4 2023-11-01 2024-10-31 10446033 2022-11-01 2023-10-31 iso4217:GBP xbrli:pure

Company No: 10446033 (England and Wales)

PAIN & NEUROMODULATION CONSULTING LTD

Unaudited Financial Statements
For the financial year ended 31 October 2024
Pages for filing with the registrar

PAIN & NEUROMODULATION CONSULTING LTD

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 October 2024

Contents

PAIN & NEUROMODULATION CONSULTING LTD

STATEMENT OF FINANCIAL POSITION

As at 31 October 2024
PAIN & NEUROMODULATION CONSULTING LTD

STATEMENT OF FINANCIAL POSITION (continued)

For the financial year ended 31 October 2024
2024 2023
£ £
Fixed assets 462,681 390,463
Current assets 103,693 124,021
Prepayments and accrued income 903 892
Creditors: amounts falling due within one year ( 33,131) ( 35,229)
Net current assets 71,465 89,684
Total assets less current liabilities 534,146 480,147
Accruals and deferred income ( 3,528) ( 3,432)
Net assets 530,618 476,715
Capital and reserves 530,618 476,715

For the financial year ending 31 October 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Pain & Neuromodulation Consulting Ltd (registered number: 10446033) were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

Simon James Thomson
Director

06 June 2025

PAIN & NEUROMODULATION CONSULTING LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024
PAIN & NEUROMODULATION CONSULTING LTD

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 October 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 10446033). The address of its registered office is 8 The Courtyard Wyncolls Road, Severalls Industrial Park, Colchester, CO4 9PE, United Kingdom.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 4 4

3. Directors’ benefits: advances, credit and guarantees

Advances

Included in current assets is a balance due from the directors of £744 (2023: £870). The balance is interest-free and repayable on demand.

Included in creditors is a balance due to one of the directors £8,398 (2023: £7,602). The balance is repayable on demand.